omalizumab · Medicine question

Which patients with chronic spontaneous urticaria are eligible for add-on treatment with Xolair (omalizumab)?

Name: Which patients with chronic spontaneous urticaria are eligible for add-on treatment with Xolair (omalizumab)?
Published: 2026-11-08T01:59:07.974Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Xolair (omalizumab) is indicated as add-on treatment for adults and adolescents aged 12 years and above with chronic spontaneous urticaria who have an inadequate response to H1 antihistamine treatment.

Sources for this answer

Xolair 150mg Solution for Injection in pre-filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 22Document updated 13 March 2024

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about omalizumab